Loading…
Loading…
OVATF does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for OVATF and 80,000+ other tickers.
See exactly how OVATF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for OVATF and 80,000+ other tickers.
Ovation Science Inc. specializes in the manufacturing of cannabis and hemp-derived products, distributing them across Canada, the United States, and Mexico. Central to its operations is Invisicare, a proprietary, patented drug delivery system. This advanced technology is incorporated into topical and transdermal skincare products, which feature hemp seed oil and cannabis, and are marketed under the Ovation and BASKiN brands. Beyond this core technology, the company offers a range of other solutions: health and wellness products infused with cannabidiol (CBD) under the Invibe MD name…
Canadian Patent Enhances Market Exclusivity and Licensing Potential Expands Global Intellectual Property Portfolio Supporting Long-Term Revenue Growth VANCOUVER, BC / ACCESS Newswire / January 7, 2026 / Ovation Science Inc. (CSE:OVAT)(OTC PINK:OVATF) ("Ovation" or the "Company"), a research and development company focused on the commercialization, patenting, and licensing of advanced cannabinoid-based topical / transdermal products, today announced the issuance of a new Canadian patent covering proprietary topical formulations containing CBD and THC. The patent, entitled "Composition and method for transdermal delivery of cannabidiol (CBD) and delta9-tetrahydrocannabinol (THC)" expands Ovation's intellectual property protection beyond its previously issued U.S. patent and significantly strengthens the Company's growing international patent portfolio.
VANCOUVER, BC AND LAS VEGAS, NV / ACCESS Newswire / December 22, 2025 / Ovation Science Inc. (CSE:OVAT)(OTC PINK:OVATF) ("Ovation" or the "Company") welcomes the recent U.S. rescheduling of cannabis and the potential introduction of a Medicare program that could allow patient access to much-needed, potentially life-changing CBD therapies, including topical formulations. Ovation's science-based topical / transdermal cannabis products are supported by clinical evidence and demonstrated commercial success through its licensee network.
VANCOUVER, BC AND LAS VEGAS, NV / ACCESS Newswire / September 18, 2025 / Ovation Science Inc. (CSE:OVAT)(OTC:OVATF) ("Ovation" or the "Company"), today announced an enhanced strategic partnership with Skinvisible Pharmaceuticals, Inc. (OTCQB:SKVI) ("Skinvisible") to leverage patent-pending Invisicare® topical and transdermal cannabis developments in the obesity market. The agreement will enhance the strategic partnership for innovative cannabinoid delivery technology with new developments and patent protection.
Expanded License Agreement Brings Ovation's Science-Based Topicals to Largest Medical Cannabis Market in the USA VANCOUVER, BC AND LAS VEGAS, NV / ACCESS Newswire / July 29, 2025 / Ovation Science Inc. (CSE:OVAT)(OTC:OVATF) ("Ovation" or the "Company"), today announced an expanded license agreement with Planet 13 Holdings, Inc. (CSE:PLTH)(OTCQX:PLNH) ("Planet 13") to bring its patented Invisicare® topical and transdermal cannabis products to the Florida market. The agreement will make Ovation's science-backed topical products available across Planet 13's extensive network of 33 Florida dispensary locations, building on the companies' on-going successful collaboration with Planet 13 in Nevada where Ovation's topicals have achieved top sales rankings statewide.
VANCOUVER, BC / ACCESSWIRE / December 4, 2024 / (CSE:OVAT)(OTC PINK:OVATF) - Ovation Science Inc. ("Ovation" or the "Company"), with its patented topical and transdermal cannabis products powered by its proprietary skin delivery technology Invisicare®, announces the official launch of its products in Pennsylvania through its licensee: PA Options for Wellness Inc. ("PA Options"). The launch marks Ovation's second licensee in the USA and is part of the Company's on-going strategy to seek leading cannabis companies as licensees, state-by-state across the US.